Device Agile_endo

Agile Esophageal

Payments companies reported to CMS as associated with Agile Esophageal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5,267associated payments (2023-2025)
133clinicians with associated payments
1company reporting

By year

2023 $1,904
2024 $1,917
2025 $1,447

Payments reported as associated with Agile Esophageal, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $2,250
Surgery $700
Thoracic Surgery (Cardiothoracic Vascular Surgery) $695
Physician Assistant $362
Internal Medicine $193
Nurse Practitioner $133

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Agile Esophageal

These are the largest totals companies reported as associated with Agile Esophageal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Matthew Nelson Grand Rapids, MI Gastroenterology (Internal Medicine) $229.91
David Carr Locke New York, NY Gastroenterology (Internal Medicine) $185.21
Nabil Noureddin La Jolla, CA Gastroenterology (Internal Medicine) $165.88
Jonathan Buscaglia East Setauket, NY Gastroenterology (Internal Medicine) $134.97
Timothy Glerum Grand Rapids, MI Nurse Practitioner $114.74
Lucas Triemstra Wyoming, MI Physician Assistant $114.73
Forrest Bethel Tucson, AZ Surgery $111.98
Dina Al Rameni Farmington, CT Thoracic Surgery (Cardiothoracic Vascular Surgery) $111.98
Leslie Ledbetter Tucson, AZ Gerontology (Nurse Practitioner) $111.98
Scott Chicotka Grand Rapids, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $111.98

Prescribed Agile Esophageal?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.